In a closely watched patent case, the Supreme Court on Monday gave drug companies broad leeway to use other companies' patented compounds in their own research, even at the earliest stages of drug development. Overturning a Federal Circuit decision, the Court's unanimous ruling in Merck KGaA v. Integra Life Sciences means companies can begin developing competing drugs and generics earlier in the life of a competitor's patent, enabling them to jump into the market as soon as a rival patent expires.
June 14, 2005 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
Legalweek New York explores Business and Regulatory Trends, Technology and Talent drivers impacting law firms.
Company DescriptionA prominent boutique AV rated Education Law firm located in Westbury, New York. Our firm specializes in education law, sp...
Seeking motivated and skilled litigation attorney to join our dynamic defense litigation firm. Role Involves:Conducting thorough research.Ha...
DEPUTY PORT ATTORNEY III Oakland, CA Salary: $17,294 - $21,419/month, 37.5-hr work week Your Port. Your Community. Your Career. Whe...
